Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial (Q34515723)

2 August 2017

title

Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial (English)

1 reference

Helicobacter pylori infectious disease

2 August 2017

0 references

1 reference

W Schwizer

1

1 reference

2 August 2017

M Thumshirn

2

1 reference

2 August 2017

J Dent

3

1 reference

2 August 2017

I Guldenschuh

4

1 reference

2 August 2017

D Menne

5

1 reference

2 August 2017

G Cathomas

6

1 reference

2 August 2017

M Fried

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

357

1 reference

2 August 2017

issue

9270

1 reference

2 August 2017

page(s)

1738-1742

1 reference

Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

The effect of Helicobacter pylori eradication on gastro-oesophageal reflux

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

Patterns of Gastroesophageal Reflux in Health and Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

Gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904894-7

7 January 2021

10.1016/S0140-6736(00)04894-7

Identifiers

DOI

1 reference

2 August 2017

1 reference